Skip to main content

Advertisement

Open Peer Review Reports for: Gemcitabine and docetaxel combination chemotherapy for advanced bone and soft tissue sarcomas: protocol for an open-label, non-randomised, Phase 2 study

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
30 Nov 2018 Submitted Original manuscript
15 Mar 2019 Reviewed Reviewer Report - Scott Okuno
24 Mar 2019 Reviewed Reviewer Report - Sandro Pasquali
23 May 2019 Author responded Author comments - Hitomi Hara
Resubmission - Version 2
23 May 2019 Submitted Manuscript version 2
2 Jun 2019 Reviewed Reviewer Report - Sandro Pasquali
9 Jun 2019 Reviewed Reviewer Report - Scott Okuno
14 Jun 2019 Author responded Author comments - Hitomi Hara
Resubmission - Version 3
14 Jun 2019 Submitted Manuscript version 3
3 Jul 2019 Reviewed Reviewer Report - Sandro Pasquali
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
11 Jul 2019 Editorially accepted
23 Jul 2019 Article published 10.1186/s12885-019-5923-7

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement